Cargando…
Keap1 hypomorphism protects against ischemic and obstructive kidney disease
The Keap1/Nrf2 pathway is a master regulator of antioxidant, anti-inflammatory, and other cytoprotective mechanisms important in protection from kidney disease. For the first time in kidney disease, we describe the use of Keap1 hypomorphic mice, which possess Nrf2 hyperactivation. We exposed these m...
Autores principales: | Tan, Roderick J., Chartoumpekis, Dionysios V., Rush, Brittney M., Zhou, Dong, Fu, Haiyan, Kensler, Thomas W., Liu, Youhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090361/ https://www.ncbi.nlm.nih.gov/pubmed/27804998 http://dx.doi.org/10.1038/srep36185 |
Ejemplares similares
-
Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism
por: Chartoumpekis, Dionysios V., et al.
Publicado: (2015) -
New Player on An Old Field; the Keap1/Nrf2 Pathway as a Target for Treatment of Type 2 Diabetes and Metabolic Syndrome
por: Chartoumpekis, Dionysios V, et al.
Publicado: (2013) -
Mice Hypomorphic for Keap1, a Negative Regulator of the Nrf2 Antioxidant Response, Show Age-Dependent Diffuse Goiter with Elevated Thyrotropin Levels
por: Ziros, Panos G., et al.
Publicado: (2021) -
The Keap1/Nrf2 Signaling Pathway in the Thyroid—2020 Update
por: Thanas, Christina, et al.
Publicado: (2020) -
A Bibliometric Review of the Keap1/Nrf2 Pathway and its Related Antioxidant Compounds
por: Paunkov, Ana, et al.
Publicado: (2019)